Lorusso V. |  Forcignano R.... -  《frontiers in bioscience (scholar edition)》 - 2012,4 S(1) - 31～42

摘要：EGFR and HER2 are highly expressed in 15-30 | % of breast cancer tissues. Therefore, EGFR and its |  downstream signaling pathways are promising anti-tumour |  targets. HER2 overexpression is often associated with |  estrogen receptor (ER) and progesterone receptor (PR

关键词： Breast cancer |  Egfr |  Her2 |  Lapatinib |  Review |  Targeted therapy |  Tirosine-kynase |  Trastuzumab